Guenter Janhofer - Oct 23, 2023 Form 3 Insider Report for Quince Therapeutics, Inc. (QNCX)

Signature
/s/ Brendan Hannah, Attorney-in-Fact for Guenter Janhofer, M.D., Ph.D.
Stock symbol
QNCX
Transactions as of
Oct 23, 2023
Transactions value $
$0
Form type
3
Date filed
10/24/2023, 07:34 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding QNCX Common Stock 15K Oct 23, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.